Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675

Benzinga · 2d ago
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.